Athyrium Capital Management, Lp - Net Worth and Insider Trading
Athyrium Capital Management, Lp Net Worth
The estimated net worth of Athyrium Capital Management, Lp is at least $913,853 dollars as of 2024-04-28. Athyrium Capital Management, Lp is the 10% Owner of Biora Therapeutics Inc and owns about 1,455,876 shares of Biora Therapeutics Inc (BIOR) stock worth over $913,853. Details can be seen in Athyrium Capital Management, Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Athyrium Capital Management, Lp has not made any transactions after 2021-06-14 and currently still holds the listed stock(s).
Transaction Summary of Athyrium Capital Management, Lp
Athyrium Capital Management, Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Athyrium Capital Management, Lp owns 1 companies in total, including Biora Therapeutics Inc (BIOR) .
Click here to see the complete history of Athyrium Capital Management, Lp’s form 4 insider trades.
Insider Ownership Summary of Athyrium Capital Management, Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BIOR | Biora Therapeutics Inc | 2021-06-14 | 10 percent owner |
Athyrium Capital Management, Lp Latest Holdings Summary
Athyrium Capital Management, Lp currently owns a total of 1 stock. Athyrium Capital Management, Lp owns 1,455,876 shares of Biora Therapeutics Inc (BIOR) as of June 14, 2021, with a value of $913,853.
Latest Holdings of Athyrium Capital Management, Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BIOR | Biora Therapeutics Inc | 2021-06-14 | 1,455,876 | 0.63 | 913,853 |
Holding Weightings of Athyrium Capital Management, Lp
Athyrium Capital Management, Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Athyrium Capital Management, Lp has made a total of 3 transactions in Biora Therapeutics Inc (BIOR) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Biora Therapeutics Inc is the acquisition of 323,887 shares on June 14, 2021, which cost Athyrium Capital Management, Lp around $20 Million.
Insider Trading History of Athyrium Capital Management, Lp
- 1
Athyrium Capital Management, Lp Trading Performance
GuruFocus tracks the stock performance after each of Athyrium Capital Management, Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Athyrium Capital Management, Lp is -25.58%. GuruFocus also compares Athyrium Capital Management, Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Athyrium Capital Management, Lp within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Athyrium Capital Management, Lp's insider trading performs compared to the benchmark.
Performance of Athyrium Capital Management, Lp
Average Return
-58.12%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.33 | -25.58 | -31.36 | -58.12 | -76.39 | -76.27 |
| Relative Return to S&P 500(%) | 9.28 | -29.53 | -45.11 | -74.85 | -81.29 | -85.8 |
Athyrium Capital Management, Lp Ownership Network
Ownership Network List of Athyrium Capital Management, Lp
Ownership Network Relation of Athyrium Capital Management, Lp
Athyrium Capital Management, Lp Owned Company Details
What does Biora Therapeutics Inc do?
Who are the key executives at Biora Therapeutics Inc?
Athyrium Capital Management, Lp is the 10 percent owner of Biora Therapeutics Inc. Other key executives at Biora Therapeutics Inc include 10 percent owner Athyrium Opportunities Iii Co-invest 1 Lp , director & Chief Executive Officer Aditya P. Mohanty , and 10 percent owner Athyrium Opportunities Fund (a) Lp .
Biora Therapeutics Inc (BIOR) Insider Trades Summary
Over the past 18 months, Athyrium Capital Management, Lp made no insider transaction in Biora Therapeutics Inc (BIOR). Other recent insider transactions involving Biora Therapeutics Inc (BIOR) include a net purchase of 12,506,250 shares made by Athyrium Opportunities Iii Co-invest 1 Lp ,
In summary, during the past 3 months, insiders sold 0 shares of Biora Therapeutics Inc (BIOR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biora Therapeutics Inc (BIOR) were sold and 500,250 shares were bought by its insiders, resulting in a net purchase of 500,250 shares.
Biora Therapeutics Inc (BIOR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biora Therapeutics Inc Insider Transactions
Athyrium Capital Management, Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Athyrium Capital Management, Lp. You might contact Athyrium Capital Management, Lp via mailing address: 505 Fifth Avenue, Floor 18, New York Ny 10017.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
